Literature DB >> 427041

Work capacity, heart rate and blood lactate responses to iron treatment.

Y Ohira, V R Edgerton, G W Gardner, B Senewiratne, R J Barnard, D R Simpson.   

Abstract

Changes in haemoglobin (Hb), work performance, heart rate and postexercise blood lactate were studied in iron deficient, anaemic subjects for 16 d following total dosage infusion of iron dextran, i.v. (30-50 ml). Six adult men and 14 women were subjects with initial Hb levels of 6.6 +/- 0.6 g/dl (mean +/- SEM) for the iron treatment group (n=10) and 8.0 +/- 0.7 for the placebo group (saline infusion, n=10). Serum levels were 0.51 +/- 0.15 and 0.67 +/- 0.12 mg/l for the two groups, respectively. Haemoglobin and maximal work time increased significantly within 4 d after iron treatment and continued to increase up to 16 d. No changes were found in the placebo subjects. Heart rates at a given exercise intensity were lower in the iron treatment group than in control subjects who had the same Hb levels but had not been treated with iron. Post-exercise venous blood lactate was similar on succeeding days after iron treatment even though the subjects reached higher work loads. These results demonstrate the treatment of iron deficient, anaemic subjects with iron dextran results in improved work capacity within 4 d and a lower heart rate at a given work load after treatment which cannot be accounted for totally by the elevation of Hb concentration.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 427041     DOI: 10.1111/j.1365-2141.1979.tb05869.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

Review 1.  Iron status in athletes. An update.

Authors:  I J Newhouse; D B Clement
Journal:  Sports Med       Date:  1988-06       Impact factor: 11.136

2.  Iron-deficiency anaemia and its effect on worker productivity and activity patterns.

Authors:  V R Edgerton; G W Gardner; Y Ohira; K A Gunawardena; B Senewiratne
Journal:  Br Med J       Date:  1979-12-15

3.  Transitory hematologic effects of moderate exercise are not influenced by iron supplementation.

Authors:  J Hegenauer; L Strause; P Saltman; D Dann; J White; R Green
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1983

4.  Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial.

Authors:  F Verdon; B Burnand; C-L Fallab Stubi; C Bonard; M Graff; A Michaud; T Bischoff; M de Vevey; J-P Studer; L Herzig; C Chapuis; J Tissot; A Pécoud; B Favrat
Journal:  BMJ       Date:  2003-05-24

5.  Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure.

Authors:  Gregory D Lewis; Marc J Semigran; Michael M Givertz; Rajeev Malhotra; Kevin J Anstrom; Adrian F Hernandez; Monica R Shah; Eugene Braunwald
Journal:  Circ Heart Fail       Date:  2016-05       Impact factor: 8.790

Review 6.  Iron and learning potential in childhood.

Authors:  B Lozoff
Journal:  Bull N Y Acad Med       Date:  1989-12

Review 7.  Hematologic disorders in the elderly.

Authors:  J R Walsh
Journal:  West J Med       Date:  1981-12

8.  Distribution and metabolism of iron in muscles of iron-deficient rats.

Authors:  Y Ohira; J Hegenauer; P Saltman; V R Edgerton
Journal:  Biol Trace Elem Res       Date:  1982-03       Impact factor: 3.738

Review 9.  Treatment of anemia in inflammatory bowel disease--systematic review and meta-analysis.

Authors:  Tomer Avni; Amir Bieber; Tali Steinmetz; Leonard Leibovici; Anat Gafter-Gvili
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

10.  Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial.

Authors:  Gerasimos Filippatos; Dimitrios Farmakis; Josep Comin Colet; Kenneth Dickstein; Thomas F Lüscher; Ronnie Willenheimer; John Parissis; Giedrius Gaudesius; Claudio Mori; Barbara von Eisenhart Rothe; Nicola Greenlaw; Ian Ford; Piotr Ponikowski; Stefan D Anker
Journal:  Eur J Heart Fail       Date:  2013-06-19       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.